Method for inducing early T memory response with short peptides anti-tumor vaccine
US11191820B2 · kind B2 · utility
2Cited by
4References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 29, 2015 |
| Grant date | Dec 7, 2021 |
| Priority date | — |
| Expiry date | May 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a therapeutic peptide T specific immune therapy for use in the treatment of a cancer of an HLA-A2 (Human Leukocyte Antigen A2) positive patient, said treatment comprises a priming period consisting in two to three administrations of said therapeutic peptide T specific immune therapy, thereby inducing a memory T cell response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.